Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for treating or/and preventing pet viral diseases and preparation method thereof

A technology for viral diseases and compositions, applied in the directions of drug combinations, allergic diseases, antiviral agents, etc., can solve problems such as the lack of suitable dosage forms for pets, improve immunity, prevent secondary infection, and be simple to operate Effect

Inactive Publication Date: 2015-04-01
CHENGDU QIANKUN VETERINARY PHARMA
View PDF4 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Enrofloxacin, as the third-generation animal-specific fluoroquinolone broad-spectrum antibacterial drug, has a good inhibitory effect on both quiescent and growing bacteria. It is the drug of choice for respiratory and intestinal diseases. It is widely used clinically in large animals, but there is no Clinically suitable dosage form for pets

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0019] The preparation of embodiment 1 medicine of the present invention

[0020] 1. After mixing 2.5g enrofloxacin and 7.5g pidotimod with 32.5g lactose and moistening with 85% ethanol, make 60-80 mesh granules, spheroidize in a spheronizer, and dry to get a ball core. Add 2.5 g of acrylic resin into 20 ml of 95% ethanol to dissolve to prepare a coating solution. Then put the pill core containing medicine in the fluidized bed tray, use coating solution to coat the pill core by fluidized bed, after drying, 5g beef extract is dissolved and carry out secondary coating, after drying, dry pressing, every Tablet weight 0.5g, 100 tablets in total, code A.

[0021] 2. After mixing 3g of enrofloxacin and 7g of pidotimod with 22.5 g of microcrystalline cellulose and wetting it with 85% ethanol, make 60-80 mesh granules, spheroidize them in a spheronizer, and dry to get a ball core. Add 7.5g of acrylic resin into 50ml of 95% ethanol to dissolve to prepare a coating solution. Then put...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a pharmaceutical composition for treating or / and preventing pet viral diseases. The pharmaceutical composition provided by the invention is a preparation prepared from the following medicinal raw materials in parts by weight: 25-50 parts of enrofloxacin, and 50-75 parts of pidotimod. The invention further provides a preparation method and use of the pharmaceutical composition. The pharmaceutical composition provided by the invention is used in the infection period of canine viral diseases and is capable of preventing secondary infection while increasing immunity; the pharmaceutical composition can be used for preventing epidemic viral diseases of infectious diseases; the pharmaceutical composition is initiatively taken by dogs; a way is unnecessary for a dog to find to take the pharmaceutical composition; and the process is simple to operate.

Description

technical field [0001] The invention relates to a pharmaceutical composition for treating or / and preventing viral diseases of pets. Background technique [0002] Companion animals are family members and one of spiritual sustenance for many people. Due to modern fast-paced life and changes in people's living environment and conditions, companion animals have become an indispensable part of many people's lives. However, most of the current veterinary drug companies focus on the research and development of drugs for large animals, and the use of companion animal drugs has its own characteristics, which directly leads to the slow development of the pet drug industry, and there is still a phenomenon that human drugs are used as pet drugs . Regarding pet diseases, because the diagnosis and treatment require professional knowledge, most pet owners cannot operate injection medicines, but can only give medicines to pets orally. However, pets have an extremely sensitive sense of sme...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K38/05A61K9/26A61P31/12A61P37/04A61K31/496
Inventor 唐华侨房春林吴学渊余琴李超杨海涵
Owner CHENGDU QIANKUN VETERINARY PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com